Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | LGALS2 | P05162 | 1/20 | 0.37 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15422703 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL8335055 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL13498636 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL15652660 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL5688674 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL20169071 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL5689526 | 1.00 | TACR2 (0.42) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL19818851 | 0.91 | LGALS3 (0.43) | TACR2SLC6A2PDPK1MTORTSHR | |
| SCHEMBL13498631 | 0.91 | SSTR1 (0.45) | SLC6A2SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL5326841 | 0.90 | LGALS3 (0.44) | TACR2SLC6A2TSHRCYP2C19CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060166278-A1 | Method for synthesizing sugar chain(s) | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-07-27 | — | — | US | claimed |
| EP-1640379-A1 | METHOD OF SYNTHESIZING SUGAR CHAIN | Mitsubishi Chemical Corporation (JP) | 2006-03-29 | — | — | EP | claimed |
| US-20190055276-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY | 2019-02-21 | — | — | US | disclosed |
| US-10059736-B2 | Ionic liquid supported synthesis | MCGILL UNIVERSITY (CA) | 2018-08-28 | — | — | US | disclosed |
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2010-02-18 | — | — | US | disclosed |
| EP-1861413-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | McGILL UNIVERSITY (CA) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006096963-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2006-09-21 | — | — | WO | disclosed |
| US-20060166278-A1 | Method for synthesizing sugar chain(s) | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1640379-A1 | METHOD OF SYNTHESIZING SUGAR CHAIN | Mitsubishi Chemical Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055276-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885SLC6A2 2824/4885PDPK1 2391/4885 |
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885SLC6A2 2824/4885PDPK1 2391/4885 |
| US-10059736-B2 | Ionic liquid supported synthesis | IGF2BP1, IGF2BP2, IGF2BP3 | TACR2 4393/4885SLC6A2 2824/4885PDPK1 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.